Clinical Trial Update: Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a vaccine therapy in combination with temozolomide and radiation for newly diagnosed glioblastoma multiforme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)
• Vaccine therapy

Snippet

Sponsor: Cancer Research UK | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED